½ÃÀ庸°í¼­
»óǰÄÚµå
1389701

ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå ±Ô¸ð : À¯Çü, ¿ëµµ ¹× Çüź° ¼¼°è ¿¹Ãø(2023-2032³â)

Branched Chain Amino Acids (BCAAs) Market Size - By Type (L-Leucine, L-Isoleucine, and L-Valine), Applications (Sports Nutrition, Food and Beverage, Animal Feed, Pharmaceuticals, Cosmetics and Personal Care), Form & Global Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 210 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÐÁö¼â¾Æ¹Ì³ë»ê(BCAA) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2032³â±îÁö CAGR 5.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´Ù¾çÇÑ ÃëÇâ¿¡ ´ëÀÀÇÏ°í ¼ÒºñÀÚÀÇ Àü¹ÝÀûÀÎ °æÇèÀ» °³¼±Çϱâ À§ÇØ ÀϺΠBCAA °ø±Þ¾÷üµéÀº »õ·Î¿î Á¦Çü°ú ¸ÀÀ» µµÀÔÇϱâ À§ÇÑ ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÆÄ¿ì´õ, ĸ½¶, À½·á¿Í °°Àº »õ·Î¿î Àü´Þ ÇüÅ µµÀÔ¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÏ·Ê·Î, ¿µ±¹¿¡ º»»ç¸¦ µÐ ±Þ¼ºÀåÇÏ´Â ½ºÆ÷Ã÷ ¿µ¾ç ºê·£µåÀÎ Applied NutritionÀº 2021³â 10¿ù, À̵¿ Áß¿¡µµ ¼·ÃëÇÒ ¼ö ÀÖ´Â 330mlÀÇ Åº»ê ĵÇü BCAA ¾Æ¹Ì³ëÇÏÀ̵巹ÀÌÆ® À½·á ¶óÀÎÀ» Ãâ½ÃÇÏ¿© ¿Â´õ°í(On-the-go) Á¦Ç°±ºÀ» È®´ëÇß½À´Ï´Ù.

À¯Çüº°·Î´Â L-¹ß¸° ºÎ¹® ½ÃÀå ±Ô¸ð´Â 2023-2032³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.3%¸¦ ±â·ÏÇÒ ¼ö ÀÖÀ¸¸ç, L-¹ß¸°Àº À°·ù, À¯Á¦Ç°, Äá·ù¿Í °°Àº ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Äǰ¿¡ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. µû¶ó¼­ ´Ù¸¥ BCAA¿Í ÇÔ²² ¿µ¾ç º¸ÃæÁ¦·Î ³Î¸® »ç¿ëµÇ¾î ´Ü¹éÁú ¿ä±¸·®ÀÌ Áõ°¡ÇÏ´Â °³ÀÎ ¹× ƯÁ¤ ÇÇÆ®´Ï½º ¸ñÇ¥¸¦ ÃæÁ·½Ã۱â À§ÇØ ¿µ¾ç º¸ÃæÁ¦·Î »ç¿ëµË´Ï´Ù. ¶ÇÇÑ »óó Ä¡À¯ ¹× Á¶Á÷ º¹±¸»Ó¸¸ ¾Æ´Ï¶ó °£ ±â´É Á¶Àý¿¡ ´ëÇÑ Á߿伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° ¼ö¿ä¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ÀǾàǰ ºÎ¹®ÀÇ ºÐÁö¼â ¾Æ¹Ì³ë»ê ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 6.4%ÀÇ ¼ºÀå·ü·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÏ¹Ý ½Ä´Ü¿¡¼­ ÃæºÐÇÑ ´Ü¹éÁúÀ» ¼·ÃëÇϱ⠾î·Á¿î ȯÀڵ鿡°Ô ¿µ¾çÀû Áö¿øÀ» Á¦°øÇϱâ À§ÇØ ÀǾàǰ Á¦Çü¿¡ ÷°¡ÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí Àֱ⠶§¹®À¸·Î ºÐ¼®µË´Ï´Ù. ¾Ï, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)°ú °°Àº ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±ÙÀ°·® À¯Áö¸¦ À§ÇÑ ´Ü¹éÁú ÇÕ¼º¿¡ BCAA, ƯÈ÷ ·ù½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é, À¯·´ÀÇ BCAA »ê¾÷ ±Ô¸ð´Â ½ºÆ÷Ã÷ ¿µ¾ç¿¡ ´ëÇÑ ÁýÁß°ú °Ç°­ ¹× ÇÇÆ®´Ï½º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ 2023³âºÎÅÍ 2032³â±îÁö 5.8%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½Ä¹°¼º Á¦Ç°ÀÇ ºÎ»óÀ¸·Î ½Ä¹°¼º ½Ä´ÜÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ ¿ÏµÎÄá, Äá ¹× ±âŸ ½Ä¹°¼º ´Ü¹éÁúÀ» ¿ø·á·Î ÇÏ´Â ½Ä¹°¼º BCAA¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ÀüÀÚ»ó°Å·¡ Ç÷§ÆûÀÇ ÆíÀǼº°ú ´Ù¾çÇÑ Á¦Ç° ¼±Åÿ¡ ´ëÇÑ Á¢±Ù¼º ¶ÇÇÑ ÀÌ Áö¿ªÀÇ Á¦Ç° È®»ê¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
    • À¯·´
  • °¡°Ý ºÐ¼®, 2022³â
  • ±â¼ú Àü¸Á
    • ÇâÈÄ ½ÃÀå µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀÌ ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ¼¼°è ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°(2018³â-2032³â)

  • ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå µ¿Çâ : À¯Çüº°
  • L-Leucine
  • L-Isoleucine
  • L-Valine

Á¦6Àå ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°(2018³â-2032³â)

  • ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå µ¿Çâ : ¿ëµµº°
  • ½ºÆ÷Ã÷ ¿µ¾ç ¹× ÇÇÆ®´Ï½º
  • ½Äǰ ¹× À½·á
  • µ¿¹°»ç·á
  • ÀǾàǰ
  • È­Àåǰ ¹× ÆÛ½º³ÎÄɾî

Á¦7Àå ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Çüź° 2018-2032³â

  • ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå µ¿Çâ : Çüź°
  • ºÐ¸»
  • ĸ½¶
  • Á¤Á¦
  • ¾×ü

Á¦8Àå ºÐÁö¼â ¾Æ¹Ì³ë»ê(BCAA) ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : 2018³â-2032³â Áö¿ªº°

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • ¸»·¹À̽þÆ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ÀÌÁýÆ®

Á¦9Àå ±â¾÷ °³¿ä

  • Ajinomoto
  • Kyowa Hakko Bio
  • Evonik
  • BASF
  • Toray Industries
  • DSM
  • Kerry Group
  • Glanbia
  • Archer Daniels Midland(ADM)
  • Cargill
  • Tate & Lyle
  • Glanbia Nutritionals
  • NOW Foods
  • Optimum Nutrition
  • MuscleTech
LSH 23.12.13

Global Branched Chain Amino Acids (BCAAs) Market size is poised to record 5.8% CAGR from 2023-2032, due to the growing dominance of e-commerce channels to render ease of access to wide range of products online.

To match the diverse preferences and enhance the overall experiences of consumers, several BCAA providers are focusing on innovations for introducing new formulations and flavors. The robust emphasis on introducing new delivery formats, such as powders, capsules, and drinks will also compliment the market growth. To cite an instance, in October 2021, the U.K.-based fast-growing sports nutrition brand Applied Nutrition introduced a new line of its BCAA amino-hydrate drinks in a 330ml carbonated can for expanding its On-the-go range.

The overall BCAAs industry is segmented based on type, form, application, and region.

In terms of type, the market size from the L-valine segment may observe 6.3% CAGR from 2023-2032. L-valine is naturally found in several protein-rich foods, such as meat, dairy products, and legumes. To that end, it is widely used as a dietary supplement in combination with other BCAAs to cater to individuals with increased protein needs and specific fitness goals. Rising importance in the regulation of liver function as well as wound healing and tissue repair will also prove favorable for the product demand.

On the basis of application, the branched chain amino acids market size from the pharmaceuticals segment is expected to expand at 6.4% growth rate up to 2032. This can be ascribed to the rising inclusion in pharmaceutical formulations to provide nutritional support for patients facing challenges in consuming adequate protein through regular dietary intake. With the growing burden of chronic illnesses, such as cancer and chronic obstructive pulmonary disease (COPD), the demand for BCAAs, especially leucine is increasing in protein synthesis to help preserve muscle mass.

Regionally, the Europe BCAAs industry size is projected to accrue 5.8% CAGR from 2023 to 2032 due to the increasing awareness of health and fitness along with the strong focus on sports nutrition.

The growing popularity of plant-based diets driven by the emerging trend of plant-based products is pushing the increasing demand for plant-based BCAAs sourced from peas, soy and other plant proteins. The ease of access to convenience and wide range of product choices in multiple e-commerce platforms will also contribute to the regional product uptake.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definition
  • 1.3 Base estimates & calculations
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data Sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Branched chain amino acids (BCAAs) industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Type trends
  • 2.4 Form trends
  • 2.5 Application trends
  • 2.6 Regional trends

Chapter 3 Branched chain amino acids (BCAAs) Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls & challenges
  • 3.3 Growth potential analysis
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Pricing analysis, 2022
  • 3.7 Technology landscape
    • 3.7.1 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Russia-Ukraine War Impact on the industry

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Branched chain amino acids (BCAAs) Market Size and Forecast, By Type 2018 - 2032

  • 5.1 Branched chain amino acids (BCAAs) Market Trends, By type
  • 5.2 L-Leucine
  • 5.3 L-Isoleucine
  • 5.4 L-Valine

Chapter 6 Branched chain amino acids (BCAAs) Market Size and Forecast, By Application 2018 - 2032

  • 6.1 Branched chain amino acids (BCAAs) Market Trends, By application
  • 6.2 Sports nutrition and fitness
  • 6.3 Food and beverage
  • 6.4 Animal feed
  • 6.5 Pharmaceuticals
  • 6.6 Cosmetics and personal care

Chapter 7 Branched chain amino acids (BCAAs) Market Size and Forecast, By Form 2018 - 2032

  • 7.1 Branched chain amino acids (BCAAs) Market Trends, By form
  • 7.2 Powder
  • 7.3 Capsule
  • 7.4 Tablet
  • 7.5 Liquid

Chapter 8 Branched chain amino acids (BCAAs) Market Size and Forecast, By Region 2018 - 2032

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Indonesia
    • 8.4.7 Malaysia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Egypt

Chapter 9 Company Profiles

  • 9.1 Ajinomoto
  • 9.2 Kyowa Hakko Bio
  • 9.3 Evonik
  • 9.4 BASF
  • 9.5 Toray Industries
  • 9.6 DSM
  • 9.7 Kerry Group
  • 9.8 Glanbia
  • 9.9 Archer Daniels Midland (ADM)
  • 9.10 Cargill
  • 9.11 Tate & Lyle
  • 9.12 Glanbia Nutritionals
  • 9.13 NOW Foods
  • 9.14 Optimum Nutrition
  • 9.15 MuscleTech
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦